REPORT ID 2608

Global Cystic Fibrosis Therapeutics Market Size, Status and Forecast 2022

Publish Date
11-Dec-17
Pages
100
Format
Electronic (PDF)

This report studies the global Cystic Fibrosis Therapeutics market, analyzes and researches the Cystic Fibrosis Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    AbbVie
    Novartis
    F. Hoffmann-La Roche
    Vertex Pharmaceuticals
    Gilead Sciences
    AstraZeneca
    Bayer
    Advanced Inhalation Therapies
    Cyclacel Pharmaceuticals
    Kamada
    Nivalis Therapeutics
    Allergan
    Anthera Pharmaceuticals
    Chiesi Farmaceutici S.p.A.
    ProQR Therapeutics
    PTC Therapeutics
    Savara
    Parion Sciences
    Pharmaxis
    Vectura Group

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    Small Molecules
    Biologics

Market segment by Application, Cystic Fibrosis Therapeutics can be split into
    Hospitals
    Clinics
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Cystic Fibrosis Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Cystic Fibrosis Therapeutics
    1.1  Cystic Fibrosis Therapeutics Market Overview
        1.1.1 Cystic Fibrosis Therapeutics Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Cystic Fibrosis Therapeutics Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Cystic Fibrosis Therapeutics Market by Type
        1.3.1 Small Molecules
        1.3.2 Biologics
    1.4 Cystic Fibrosis Therapeutics Market by End Users/Application
        1.4.1 Hospitals
        1.4.2 Clinics
        1.4.3 Other

2 Global Cystic Fibrosis Therapeutics Competition Analysis by Players
    2.1 Cystic Fibrosis Therapeutics Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 AbbVie
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Novartis
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 F. Hoffmann-La Roche
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Vertex Pharmaceuticals
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Gilead Sciences
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 AstraZeneca
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Bayer
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Advanced Inhalation Therapies
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Cyclacel Pharmaceuticals
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Kamada
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Nivalis Therapeutics
    3.12 Allergan
    3.13 Anthera Pharmaceuticals
    3.14 Chiesi Farmaceutici S.p.A.
    3.15 ProQR Therapeutics
    3.16 PTC Therapeutics
    3.17 Savara
    3.18 Parion Sciences
    3.19 Pharmaxis
    3.20 Vectura Group

4 Global Cystic Fibrosis Therapeutics Market Size by Type and Application (2012-2017)
    4.1 Global Cystic Fibrosis Therapeutics Market Size by Type (2012-2017)
    4.2 Global Cystic Fibrosis Therapeutics Market Size by Application (2012-2017)
    4.3 Potential Application of Cystic Fibrosis Therapeutics in Future
    4.4 Top Consumer/End Users of Cystic Fibrosis Therapeutics

5 United States Cystic Fibrosis Therapeutics Development Status and Outlook
    5.1 United States Cystic Fibrosis Therapeutics Market Size (2012-2017)
    5.2 United States Cystic Fibrosis Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU Cystic Fibrosis Therapeutics Development Status and Outlook
    6.1 EU Cystic Fibrosis Therapeutics Market Size (2012-2017)
    6.2 EU Cystic Fibrosis Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 Japan Cystic Fibrosis Therapeutics Development Status and Outlook
    7.1 Japan Cystic Fibrosis Therapeutics Market Size (2012-2017)
    7.2 Japan Cystic Fibrosis Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 China Cystic Fibrosis Therapeutics Development Status and Outlook
    8.1 China Cystic Fibrosis Therapeutics Market Size (2012-2017)
    8.2 China Cystic Fibrosis Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 India Cystic Fibrosis Therapeutics Development Status and Outlook
    9.1 India Cystic Fibrosis Therapeutics Market Size (2012-2017)
    9.2 India Cystic Fibrosis Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Cystic Fibrosis Therapeutics Development Status and Outlook
    10.1 Southeast Asia Cystic Fibrosis Therapeutics Market Size (2012-2017)
    10.2 Southeast Asia Cystic Fibrosis Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Cystic Fibrosis Therapeutics Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Cystic Fibrosis Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.2 EU Cystic Fibrosis Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Cystic Fibrosis Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.4 China Cystic Fibrosis Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.5 India Cystic Fibrosis Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Cystic Fibrosis Therapeutics Revenue and Growth Rate (2017-2022)
    11.2 Global Cystic Fibrosis Therapeutics Market Size (Value) by Type (2017-2022)
    11.3 Global Cystic Fibrosis Therapeutics Market Size by Application (2017-2022)

12 Cystic Fibrosis Therapeutics Market Dynamics
    12.1 Cystic Fibrosis Therapeutics Market Opportunities
    12.2 Cystic Fibrosis Therapeutics Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Cystic Fibrosis Therapeutics Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Cystic Fibrosis Therapeutics Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source